Denali Therapeutics

Filed a patent for "compounds, compositions, and methods" on Fri, July 21, 2023

Filed a patent for "compounds, compositions, and methods" on Fri, July 14, 2023

Filed a patent for "formulation, solid dosage form, and methods" on Thu, July 20, 2023

Filed a patent for "compounds, compositions, and methods" on Wed, September 6, 2023

Filed a patent for "anti-her2 antibodies and methods of use thereof" on Thu, February 22, 2024

Filed a patent for "dual transporters and methods of use" on Tue, June 20, 2023

Filed a patent for "anti-pilra antibodies, uses thereof, and related methods and reagents" on Wed, June 21, 2023

Filed a patent for "compositions and methods for modulating tau expression" on Thu, June 22, 2023

Filed a patent for "compounds, compositions, and methods" on Fri, December 16, 2022

Filed a patent for "cd98 heavy chain transgenic models" on Fri, December 16, 2022

Filed a patent for "methods and compositions related to engineered transferrin receptor-binding molecules" on Fri, December 16, 2022

Filed a patent for "abeta-targeting proteins and methods of use" on Fri, March 24, 2023

Filed a patent for "compounds, compositions, and methods" on Fri, April 14, 2023

Filed a patent for "methods of increasing sialic acid levels in recombinant glycosylated proteins" on Fri, April 21, 2023

Filed a patent for "compounds, compositions, and methods" on Thu, June 1, 2023

Filed a patent for "compounds, compositions, and methods" on Thu, June 1, 2023

Filed a patent for "compounds, compositions, and methods" on Wed, September 6, 2023

Filed a patent for "crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-b][1,4]oxazepin-3-yl)-4h-1,2,4-triazole-3-carboxamide" on Thu, November 28, 2024

Filed a patent for "methods for the treatment of hunter syndrome" on Fri, January 19, 2024

Filed a patent for "solid forms of 4-(3,3-difluoro-2,2-dimethyl-propanoyl)-3,5-dihydro-2h-pyrido[3,4-f][1,4]oxazepine-9-carbonitrile" on Thu, September 26, 2024

Filed a patent for "engineered anti-her2 bispecific proteins" on Thu, February 22, 2024

Filed a patent for "fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof" on Thu, March 2, 2023

Filed a patent for "methods for the treatment of hunter syndrome" on Thu, March 23, 2023

Filed a patent for "engineered anti-her2 bispecific proteins" on Thu, June 22, 2023

Filed a patent for "modulators of eukaryotic initiation factor 2" on Thu, August 25, 2022